We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMEA Drafts Guidance on Tissue-Based Advanced Therapy Medicinal Products
EMEA Drafts Guidance on Tissue-Based Advanced Therapy Medicinal Products
March 15, 2007
The European Medicines Agency (EMEA) recently published draft guidance for industry on technical requirements for marketing authorization applications for human tissue-engineered products (hTEPs).
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor